Human gingival fibroblast migration promoted by platelet-derived growth factor on titanium is correlated with release of urokinase type plasminogen activator.
The purpose of this study was to examine if the migration of human gingival fibroblasts on titanium was promoted by platelet-derived growth factor (PDGF) and whether the release of urokinase-type plasminogen activator (uPA) was correlated with it. The migration of the fibroblast on titanium was significantly promoted by PDGF in a wound healing assay (p < 0.001). The promotive effect was inhibited by aprotinin, a serine protease inhibitor used for the inhibition of uPA (p < 0.001). The conditioned medium when fibroblast migration was promoted contained a higher concentration of uPA than did that of the control. These results indicated that the promotive effect of PDGF on the migration of human gingival fibroblasts on titanium was correlated with the release of uPA from the fibroblasts.
Abiko
Y
Y
Department of Oral Pathology, School of Dentistry, Health Sciences University of Hokkaido, Japan.
Arai
J
J
Matsuzawa
K
K
Inoue
T
T
Shimono
M
M
Kaku
T
T
D007611:Aprotinin / Q000494:pharmacology; D002465:Cell Movement / Q000187:drug effects*; D002478:Cells, Cultured; D004789:Enzyme Activation; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology*; D005881:Gingiva / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D010960:Plasminogen Activators / Q000378:metabolism*; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology*; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology; D014025:Titanium; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism*
D010982:Platelet-Derived Growth Factor; D015842:Serine Proteinase Inhibitors; D007611:Aprotinin; D014025:Titanium; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator